MEDGm Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.3/10
Best for: brand Wegovy, Zepbound or Ozempic access alongside cheaper compounded GLP-1
MEDGm scores highest on the strength of its clinical program — drug options and dosing support.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
MEDGm is a Delaware telehealth platform selling compounded GLP-1 injections from $179/mo and a daily dissolvable GLP-1 tablet from $249/mo, with clinical care delivered by OpenLoop Health providers and four named US compounding pharmacies. Brand Wegovy, Zepbound and Ozempic are offered as a membership fee ($99-$171/mo) plus the drug's own cost. Cash-pay only; the plan fee is billed upfront for the term you pick and is non-refundable.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to MEDGm
Editorial score · methodology
TMates
Best for: nationwide compounded GLP-1 availability including Puerto Rico
Editorial score · methodology
Editorial score · methodology
MEDGm at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Wegovy, Zepbound, Ozempic
- Starting price
- $99/mo
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored MEDGm
Each dimension is scored algorithmically from MEDGm’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.7/10At $179/mo, MEDGm runs about 6% above the $169 median for GLP-1 providers.
Effectiveness25%
8.4/10MEDGm offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. FDA-approved brand options are available alongside compounded versions. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
7.2/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
7.2/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-09-01).
Accessibility10%
8.1/10MEDGm treats patients in all 50 states.
Support10%
5.7/10MEDGm provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this MEDGm review
Last checked September 2026- Confirmed current pricing across 5 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What to expect when you sign up with MEDGm
We walked MEDGm’s public signup flow in September 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Prices come first: medgm.org/glp-1 posts 'Starting at $179' for the weekly compounded GLP-1 injection and '$249' for the daily tablet before you start anything.
- 2Quiz step one asks height, weight and goal weight, and scores your BMI live on the same screen.
- 3Next screens take sex assigned at birth, date of birth (it states ages 18-74 are eligible) and state of residence; the state list covers all 50 states plus Washington D.C.
- 4A health check runs several 'select all that apply' screens — kidney and liver disease, eating disorders, cancer, pregnancy, bariatric surgery, thyroid and heart conditions — then blood pressure and resting heart rate ranges.
- 5Medication history, formulation preferences and a free-text note to the clinician follow.
- 6A 'Your medical review' summary appears, and then the funnel asks for first name, last name, email and phone before it will show any plan or checkout. We stopped at that gate.
- The monthly price is public, but the 3-, 6- and 12-month bundle prices the Terms describe never appear before the contact-details gate, so you cannot compare terms without handing over your email and phone.
- The summary screen prints 'Eligibility status: Likely' and 'Success probability 100%' before any clinician has seen your answers — it is generated by the quiz, not by a provider.
- The Terms are explicit that an OpenLoop Health clinician meets you after payment, and that the plan fee for the whole term is billed upfront and non-refundable outside a medical disqualification.
- Canceling requires notice at least 72 hours before the renewal date, through the member portal or support@medgm.org; canceling mid-term does not refund the rest of the term.
- A Trustpilot five-star badge sits in the quiz header, but MEDGm's Trustpilot profile — claimed in April 2026 — carried 0 reviews and a 0.0 rating when we checked it on 2026-09-01.
- The footer LegitScript seal is a self-hosted image rather than a LegitScript-served seal, and LegitScript's own lookup was rate-limited when we checked, so we could not confirm a certification record either way.
MEDGm customer support
- Phone
- +1 (214) 667-2145
- support@medgm.org
- Hours
- Site describes a 24/7 patient support line; specific hours are not published
GLP-1 medications MEDGm offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
'Starting at $179' on medgm.org/glp-1. MEDGm never names the molecule for its compounded products on the public site. 3-, 6- and 12-month bundles exist but are priced only at checkout, behind a name/email/phone gate.
'Starting at $249' on medgm.org/glp-1, verified 2026-09-01. Molecule not published.
'$99 Membership + Cost' — the medication cost is not published. 'Availability is subject to change.'
'$99 Membership + Cost' — the medication cost is not published. 'Availability is subject to change.'
'$171 Membership + Cost' — the medication cost is not published. Ozempic is FDA-approved for type 2 diabetes and prescribed off-label here.
Ready to get started?
Plans and promotions change often — check MEDGm's current pricing and active discounts before you decide.
What we like
- Compounded GLP-1 injections from $179/mo with medication, clinician access and shipping in one price
- A daily dissolvable tablet for people who do not want to inject, at $249/mo
- Brand Wegovy, Zepbound and Ozempic available on a membership-plus-medication basis
- Four named US pharmacy partners with addresses (RedRock, Health Warehouse, Precision Medicine, Triad Rx)
- Clinical care through the OpenLoop Health provider network; service listed in all 50 states and DC
- Published support line and email, with a 24/7 patient support line described in the refund policy
Watch-outs
- The molecule behind the compounded injection and tablet is never named on the public site
- You pay before a clinician reviews you — the Terms say the consult happens after the fee is charged
- The plan fee is billed upfront for the whole term and is non-refundable, except for a documented medical disqualification
- Canceling a 3-, 6- or 12-month bundle mid-term refunds nothing; you must give notice 72 hours before renewal
- Bundle prices are not shown until you hand over your name, email and phone
- A Trustpilot five-star badge runs in the quiz, but the Trustpilot profile showed 0 reviews and a 0.0 rating on 2026-09-01
- Site disclaimers state that images and other content may be AI-generated and that people in ads may be actors or AI
- Compounded GLP-1s are not FDA-approved
Is MEDGm worth it? Our verdict
MEDGm positions itself around one thing: brand Wegovy, Zepbound or Ozempic access alongside cheaper compounded GLP-1. It runs $179/month. Its standout is a needle-free oral option, which very few providers offer.
Where MEDGm tries to set itself apart is the extras: Wegovy, Zepbound, and Ozempic.
How much MEDGm actually costs
- Compounded GLP-1 injection (weekly), monthly plan — $179/month
- Compounded GLP-1 oral tablet (one dissolvable tablet daily) — $249/month
- Brand-name tirzepatide — $99/month
- Brand-name semaglutide — $99/month
- Brand-name semaglutide — $171/month
That's roughly in line with the ~$169/month median across the GLP-1 providers we track.
For a direct comparison, DudeMeds runs semaglutide and tirzepatide from $175/month — worth pricing against MEDGm before you commit.
Medications: what MEDGm prescribes
MEDGm prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. You can choose FDA-approved brand-name pens or lower-cost compounded versions — the compounded route is how the monthly price stays down, with the trade-off that compounded drugs aren't FDA-approved as finished products.
MEDGm's needle-free oral option is a real draw if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used, so treat it as a convenience option rather than a proven equal to the shot.
Who MEDGm is best for — and who should skip it
A good fit if you…
- are needle-averse and want a non-injectable option.
- live anywhere in the US and want guaranteed access.
Look elsewhere if you…
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
MEDGm treats patients in all 50 states. We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
MEDGm is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding. If you're comparison-shopping, Bodybuilding Health+ is one of the closest alternatives we track — worth a look before deciding.
The Bottom Line
MEDGm scores highest on the strength of its clinical program — drug options and dosing support.
Ready to start with MEDGm?
Starting at $179/month. See current pricing and start your free consultation.
MEDGm might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this MEDGm review:
Sources & methodology — as of September 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See MEDGm's current pricing
Plans start at $179/month. Start your free consultation to check eligibility and today's price.